Dimeric FcγR Ectodomains as Probes of the Fc Receptor Function of Anti-Influenza Virus IgG. (Q30390233)

21 June 2017

title

Dimeric FcγR Ectodomains as Probes of the Fc Receptor Function of Anti-Influenza Virus IgG. (English)

1 reference

Anne Bregnballe Kristensen

21 June 2017

author

object named as

Anne B Kristensen

4

0 references

Stephen J. Kent

object named as

Stephen J Kent

5

0 references

author name string

Bruce D Wines

1

1 reference

21 June 2017

Hillary A Vanderven

2

1 reference

21 June 2017

Sandra E Esparon

3

1 reference

21 June 2017

P Mark Hogarth

6

1 reference

21 June 2017

language of work or name

English

0 references

publication date

6 July 2016

1 reference

21 June 2017

published in

Journal of Immunology

1 reference

21 June 2017

volume

197

1 reference

21 June 2017

issue

4

1 reference

21 June 2017

page(s)

1507-1516

1 reference

Epitope specificity of human immunodeficiency virus-1 antibody dependent cellular cytotoxicity [ADCC] responses

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Antibody-dependent cell-mediated cytotoxicity against influenza virus-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

HIV-specific antibody immunity mediated through NK cells and monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Influenza-specific antibody-dependent cellular cytotoxicity: toward a universal influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Antibody-dependent cellular cytotoxicity is associated with control of pandemic H1N1 influenza virus infection of macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Fc receptor but not complement binding is important in antibody protection against HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Broadly neutralizing anti-HIV-1 antibodies require Fc effector functions for in vivo activity

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Vaccine induced antibodies to the first variable loop of human immunodeficiency virus type 1 gp120, mediate antibody-dependent virus inhibition in macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Type II and III receptors for immunoglobulin G (IgG) control the presentation of different T cell epitopes from single IgG-complexed antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Selective blockade of inhibitory Fcgamma receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Fc gamma receptors regulate immune activation and susceptibility during Mycobacterium tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Differential Fc-Receptor Engagement Drives an Anti-tumor Vaccinal Effect

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Glyco-engineered anti-EGFR mAb elicits ADCC by NK cells from colorectal cancer patients irrespective of chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Antibody therapeutics in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Structure of FcγRI in complex with Fc reveals the importance of glycan recognition for high-affinity IgG binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Crystal Structure of Fc Receptor I and Its Implication in High Affinity -Immunoglobulin Binding

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Crystal structure of the human leukocyte Fc receptor, Fc gammaRIIa

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Structural Basis for Fc RIIa Recognition of Human IgG and Formation of Inflammatory Signaling Complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Crystal structure of the soluble form of the human fcgamma-receptor IIb: a new member of the immunoglobulin superfamily at 1.7 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

The structure of a human type III Fcgamma receptor in complex with Fc

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

The interactions of therapeutic antibodies with Fc receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Impact of immune complex size and glycosylation on IgG binding to human FcγRs

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Structural Definition of an Antibody-Dependent Cellular Cytotoxicity Response Implicated in Reduced Risk for HIV-1 Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Development of a robust reporter-based ADCC assay with frozen, thaw-and-use cells to measure Fc effector function of therapeutic antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Characterization of in vitro antibody-dependent cell-mediated cytotoxicity activity of therapeutic antibodies - impact of effector cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Two mechanisms of the enhanced antibody-dependent cellular cytotoxicity (ADCC) efficacy of non-fucosylated therapeutic antibodies in human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Effects of cryopreservation on effector cells for antibody dependent cell-mediated cytotoxicity (ADCC) and natural killer (NK) cell activity in (51)Cr-release and CD107a assays

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

High reproducible ADCC analysis revealed a competitive relation between ADCC and CDC and differences between FcγRllla polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Development of a cell-based assay measuring the activation of FcγRIIa for the characterization of therapeutic monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Targeting quantum dots to surface proteins in living cells with biotin ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Structural basis for evasion of IgA immunity by Staphylococcus aureus revealed in the complex of SSL7 with Fc of human IgA1

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Molecular cloning of a human immunoglobulin G Fc receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Specificity of staphylococcal superantigen-like protein 10 toward the human IgG1 Fc domain

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Rapid expression of an anti-human C5 chimeric Fab utilizing a vector that replicates in COS and 293 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

SignalP 4.0: discriminating signal peptides from transmembrane regions

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Standard trivalent influenza virus protein vaccination does not prime antibody-dependent cellular cytotoxicity in macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Age-associated cross-reactive antibody-dependent cellular cytotoxicity toward 2009 pandemic influenza A virus subtype H1N1.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity in intravenous immunoglobulin as a potential therapeutic against emerging influenza viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Glycoengineered CD20 antibody obinutuzumab activates neutrophils and mediates phagocytosis through CD16B more efficiently than rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

FcγR dependent mechanisms of cytotoxic, agonistic, and neutralizing antibody activities

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Precise determination of the diversity of a combinatorial antibody library gives insight into the human immunoglobulin repertoire

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Highly parallel characterization of IgG Fc binding interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Enhanced phagocytic activity of HIV-specific antibodies correlates with natural production of immunoglobulins with skewed affinity for FcγR2a and FcγR2b

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Polyfunctional HIV-Specific Antibody Responses Are Associated with Spontaneous HIV Control

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

High-throughput, multiplexed IgG subclassing of antigen-specific antibodies from clinical samples

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Quantitative evaluation of fucose reducing effects in a humanized antibody on Fcγ receptor binding and antibody-dependent cell-mediated cytotoxicity activities

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Mechanisms mediating enhanced neutralization efficacy of staphylococcal enterotoxin B by combinations of monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

Treatment with monoclonal antibodies against Clostridium difficile toxins

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1502551

21 January 2018

Identifiers

DOI

10.4049/JIMMUNOL.1502551

1 reference

21 June 2017

1 reference